YDES
Yd Bio Ltd
NASDAQ · Biotechnology
$11.28
+0.52 (+4.83%)
Income Statement
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Revenue | 515.6K | 122.20M | 119.09M | 134.19M |
| Net Income | -1,432,336 | 29.08M | 25.78M | 25.78M |
| EPS | — | — | — | — |
| Profit Margin | -276.6% | 23.8% | 21.7% | 19.2% |
| Rev Growth | — | +2.9% | +5.6% | -10.0% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Total Debt | 2.29M | 239.43M | 188.25M | 198.79M |
| Total Equity | 401.63M | 534.41M | 574.88M | 548.17M |
| D/E Ratio | 0.01 | 0.45 | 0.33 | 0.36 |
Cash Flow
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| EBITDA | -1,410,851 | 41.35M | 38.15M | 43.54M |
| Free Cash Flow | — | 33.20M | 25.74M | 34.14M |